NIEHS and NCL/NCI announce partnership to study nanotechnology safety

The National Cancer Institute (NCI)'s Nanotechnology Characterization Laboratory (NCL), part of NCI's Alliance for Nanotechnology in Cancer, is an accomplished source for testing nanomaterials for biomedical applications and is now partnering with the National Institute of Environmental Health Sciences (NIEHS) to characterize engineered nanomaterials used in risk/hazard studies.

Related Posts

Comments are closed.